It’s Hard to Measure Success While Caring for Surges in Coronavirus Disease 2019 (COVID-19) Hospitalizations

Gottlieb, Lindsey; Fridkin, Scott K.

doi:10.1093/cid/ciab740

Cited by 2 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…17 Proposed explanations for the rise in the incidence of HAI and MDRO acquisition since the earliest months of the pandemic include staffing shortages, higher patient acuity leading to greater and prolonged use of invasive devices, and diversion of infection control staff to COVID-19-related tasks. 18 The care of COVID-19 patients in the hospital setting presents challenges in infection prevention and control above and beyond those of standard inpatient care. Among these challenges are engineering requirements unique to COVID-19 isolation units, cumbersome requirements for use of PPE, the concentration of acutely ill patients with a range of comorbidities, who would normally be cared for in specialized wards, and healthcare workers' fear of contracting COVID-19.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Hospital-acquired bacterial infections in coronavirus disease 2019 (COVID-19) patients in Israel

Schwaber

Temkin

Lobl

et al. 2022

Infect. Control Hosp. Epidemiol.

View full text Add to dashboard Cite

Background: We sought to determine incidence of common hospital-acquired bacteria among coronavirus disease 2019 (COVID-19) patients in Israeli general hospitals during the first year of the pandemic. Methods: We analyzed routinely collected incidence data to determine hospital acquisition of the following sentinel bacteria: Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, Pseudomonas aeruginosa, Acinetobacter baumannii, and Clostridioides difficile. We examined 3 acquisition measures: (1) sentinel bacteria, (2) sentinel bacteremia, and (3) antimicrobial-resistant sentinel bacteremia. The study period was March 1, 2020, through January 31, 2021. Results: Analysis of pooled data from the 26 hospitals surveyed revealed that rates were higher for all 3 acquisition measures among COVID-19 patients than they were among patients on general medical wards in 2019, but lower than those among patients in intensive care units in 2019. The incidence rate was highest during the first COVID-19 wave, despite a lower proportion of severe COVID-19 cases among total hospitalized during this wave. Wide variation in incidence was evident between hospitals. Conclusions: Hospitalized COVID-19 patients experienced nosocomial bacterial infection at rates higher than those of patients on pre-pandemic general medical wards, adding to the complexity of their care. Lower rates of nosocomial infection after the first wave, despite higher proportions of severely ill patients, suggest that healthcare worker practices, rather than patient-related factors, were responsible for most of these infections.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Hospital-acquired bacterial infections in coronavirus disease 2019 (COVID-19) patients in Israel

Schwaber

Temkin

Lobl

et al. 2022

Infect. Control Hosp. Epidemiol.

View full text Add to dashboard Cite

show abstract

Trends in Pseudomonas aeruginosa (P. aeruginosa) Bacteremia during the COVID-19 Pandemic: A Systematic Review

Ong

Lee

et al. 2023

Antibiotics

View full text Add to dashboard Cite

Pseudomonas aeruginosa (P. aeruginosa) is among the most common pathogens associated with healthcare-acquired infections, and is often antibiotic resistant, causing significant morbidity and mortality in cases of P. aeruginosa bacteremia. It remains unclear how the incidence of P. aeruginosa bacteremia changed during the Coronavirus Disease 2019 (COVID-19) pandemic, with studies showing almost contradictory conclusions despite enhanced infection control practices during the pandemic. This systematic review sought to examine published reports with incidence rates for P. aeruginosa bacteremia during (defined as from March 2020 onwards) and prior to the COVID-19 pandemic. A systematic literature search was conducted in accordance with PRISMA guidelines and performed in Cochrane, Embase, and Medline with combinations of the key words (pseudomonas aeruginosa OR PAE) AND (incidence OR surveillance), from database inception until 1 December 2022. Based on the pre-defined inclusion criteria, a total of eight studies were eligible for review. Prior to the pandemic, the prevalence of P. aeruginosa was on an uptrend. Several international reports found a slight increase in the incidence of P. aeruginosa bacteremia during the COVID-19 pandemic. These findings collectively highlight the continued importance of good infection prevention and control and antimicrobial stewardship during both pandemic and non-pandemic periods. It is important to implement effective infection prevention and control measures, including ensuring hand hygiene, stepping up environmental cleaning and disinfection efforts, and developing timely guidelines on the appropriate prescription of antibiotics.

show abstract

It’s Hard to Measure Success While Caring for Surges in Coronavirus Disease 2019 (COVID-19) Hospitalizations

Cited by 2 publications

References 7 publications

Hospital-acquired bacterial infections in coronavirus disease 2019 (COVID-19) patients in Israel

Hospital-acquired bacterial infections in coronavirus disease 2019 (COVID-19) patients in Israel

Trends in Pseudomonas aeruginosa (P. aeruginosa) Bacteremia during the COVID-19 Pandemic: A Systematic Review

Contact Info

Product

Resources

About